Hypothalamic α-synuclein and its relation to autonomic symptoms and neuroendocrine abnormalities in Parkinson disease

Adamantidis, 2007, Neural substrates of awakening probed with optogenetic control of hypocretin neurons, Nature, 450, 420, 10.1038/nature06310 Adler, 2016, Neuropathological basis of nonmotor manifestations of Parkinson's disease, Mov Disord, 31, 1114, 10.1002/mds.26605 Adler, 2019, Unified staging system for Lewy body disorders: clinicopathologic correlations and comparison to Braak staging, J Neuropathol Exp Neurol, 78, 891, 10.1093/jnen/nlz080 Albers, 2017, Multifactorial sleep disturbance in Parkinson's disease, Sleep Med, 35, 41, 10.1016/j.sleep.2017.03.026 An, 2013, A neuropeptide speeds circadian entrainment by reducing intercellular synchrony, Proc Natl Acad Sci U S A, 110, E4355, 10.1073/pnas.1307088110 Ansorge, 1997, Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease, Neurology, 49, 610, 10.1212/WNL.49.2.610 Arnulf, 2000, Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis, Neurology, 55, 281, 10.1212/WNL.55.2.281 Asahina, 2013, Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology, J Neurol Neurosurg Psychiatry, 84, 674, 10.1136/jnnp-2012-303135 Bannier, 2009, Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up, J Neurol Neurosurg Psychiatry, 80, 484, 10.1136/jnnp.2008.158576 Barichella, 2003, Body weight gain rate in patients with Parkinson's disease and deep brain stimulation, Mov Disord, 18, 1337, 10.1002/mds.10543 Baumann, 2005, Parkinsonism with excessive daytime sleepiness—a narcolepsy-like disorder?, J Neurol, 252, 139, 10.1007/s00415-005-0614-5 Beach, 2010, Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders, Acta Neuropathol, 119, 689, 10.1007/s00401-010-0664-3 Benarroch, 2005, Paraventricular nucleus, stress response, and cardiovascular disease, Clin Auton Res, 15, 254, 10.1007/s10286-005-0290-7 Benarroch, 2008, Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations, Neurology, 71, 594, 10.1212/01.wnl.0000324283.57261.37 Benarroch, 2010, Neural control of feeding behavior: overview and clinical correlations, Neurology, 74, 1643, 10.1212/WNL.0b013e3181df0a3f Benarroch, 2015, Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies, Mov Disord, 30, 1133, 10.1002/mds.26287 Bonuccelli, 2000, Diurnal motor variations to repeated doses of levodopa in Parkinson's disease, Clin Neuropharmacol, 23, 28, 10.1097/00002826-200001000-00006 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Breen, 2014, Sleep and circadian rhythm regulation in early Parkinson disease, JAMA Neurol, 71, 589, 10.1001/jamaneurol.2014.65 Breen, 2016, Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease, Mov Disord, 31, 1062, 10.1002/mds.26592 Buijs, 2013, The circadian system and the balance of the autonomic nervous system, Handb Clin Neurol, 117, 173, 10.1016/B978-0-444-53491-0.00015-8 Cai, 2010, Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease, Eur J Neurol, 17, 550, 10.1111/j.1468-1331.2009.02848.x Cersosimo, 2012, Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers, J Neurol Sci, 313, 57, 10.1016/j.jns.2011.09.030 Cersosimo, 2013, Central control of autonomic function and involvement in neurodegenerative disorders, Handb Clin Neurol, 117, 45, 10.1016/B978-0-444-53491-0.00005-5 Chaudhuri, 2006, Non-motor symptoms of Parkinson's disease: diagnosis and management, Lancet Neurol, 5, 235, 10.1016/S1474-4422(06)70373-8 Chen, 2003, Weight loss in Parkinson's disease, Ann Neurol, 53, 676, 10.1002/ana.10577 Claustrat, 2005, The basic physiology and pathophysiology of melatonin, Sleep Med Rev, 9, 11, 10.1016/j.smrv.2004.08.001 Compta, 2009, Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia, Brain, 132, 3308, 10.1093/brain/awp263 Coon, 2018, Neuropathology of autonomic dysfunction in synucleinopathies, Mov Disord, 33, 349, 10.1002/mds.27186 Cunningham, 2002, Cardiovascular regulation of supraoptic vasopressin neurons, Prog Brain Res, 139, 257 Dayan, 2018, Disrupted hypothalamic functional connectivity in patients with PD and autonomic dysfunction, Neurology, 90, e2051, 10.1212/WNL.0000000000005641 De Pablo-Fernandez, 2017, Neuroendocrine abnormalities in Parkinson's disease, J Neurol Neurosurg Psychiatry, 88, 176, 10.1136/jnnp-2016-314601 De Pablo-Fernandez, 2017, Hypothalamic alpha-synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease, Mov Disord, 32, 296, 10.1002/mds.26868 De Pablo-Fernandez, 2017, Association of autonomic dysfunction with disease progression and survival in Parkinson disease, JAMA Neurol, 74, 970, 10.1001/jamaneurol.2017.1125 De Pablo-Fernandez, 2018, A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy, JAMA Neurol, 75, 1008, 10.1001/jamaneurol.2018.0640 Delikanaki-Skaribas, 2009, Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients, Mov Disord, 24, 667, 10.1002/mds.22372 DelleDonne, 2008, Incidental Lewy body disease and preclinical Parkinson disease, Arch Neurol, 65, 1074, 10.1001/archneur.65.8.1074 Dickson, 2008, Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease, Acta Neuropathol, 115, 437, 10.1007/s00401-008-0345-7 Dickson, 2009, Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria, Lancet Neurol, 8, 1150, 10.1016/S1474-4422(09)70238-8 Ding, 2011, Decreased expression of Bmal2 in patients with Parkinson's disease, Neurosci Lett, 499, 186, 10.1016/j.neulet.2011.05.058 Djamshidian, 2011, Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour, J Neurol Neurosurg Psychiatry, 82, 1107, 10.1136/jnnp.2011.245746 Doorn KJ, Lucassen PJ, Boddeke HW et al. (2012). Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol 98: 222–238. https://doi.org/10.1016/j.pneurobio.2012.06.005. Doorn KJ, Moors T, Drukarch B et al. (2014). Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients. Acta Neuropathol Commun 2: 90. https://doi.org/10.1186/s40478-014-0090-1. Drouot, 2003, Low levels of ventricular CSF orexin/hypocretin in advanced PD, Neurology, 61, 540, 10.1212/01.WNL.0000078194.53210.48 Espay, 2016, Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets, Lancet Neurol, 15, 954, 10.1016/S1474-4422(16)30079-5 Ferguson, 2008, The paraventricular nucleus of the hypothalamus—a potential target for integrative treatment of autonomic dysfunction, Expert Opin Ther Targets, 12, 717, 10.1517/14728222.12.6.717 Fronczek, 2007, Hypocretin (orexin) loss in Parkinson's disease, Brain, 130, 1577, 10.1093/brain/awm090 Gelpi, 2014, Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders, Mov Disord, 29, 1010, 10.1002/mds.25776 Gibb, 1989, The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease, Neuropathol Appl Neurobiol, 15, 27, 10.1111/j.1365-2990.1989.tb01147.x Haapaniemi, 2001, Ambulatory ECG and analysis of heart rate variability in Parkinson's disease, J Neurol Neurosurg Psychiatry, 70, 305, 10.1136/jnnp.70.3.305 Hartmann, 1997, Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation, Neurobiol Aging, 18, 285, 10.1016/S0197-4580(97)80309-0 Ikeda, 2007, Body mass index and the risk of Parkinson disease, Neurology, 68, 2156, 10.1212/01.wnl.0000269477.49238.ec Jellinger, 2015, Neuropathobiology of non-motor symptoms in Parkinson disease, J Neural Transm, 10.1007/s00702-015-1405-5 Kalaitzakis, 2013, Disturbed sleep in Parkinson's disease: anatomical and pathological correlates, Neuropathol Appl Neurobiol, 39, 644, 10.1111/nan.12024 Keir, 2019, New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease, J Neurol, 267, 288, 10.1007/s00415-019-09651-z Kistner, 2014, Mechanisms of body weight fluctuations in Parkinson's disease, Front Neurol, 5, 84, 10.3389/fneur.2014.00084 Krack, 2003, Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease, N Engl J Med, 349, 1925, 10.1056/NEJMoa035275 Kremer, 1993, Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?, Mov Disord, 8, 315, 10.1002/mds.870080310 Langston, 1978, The hypothalamus in Parkinson disease, Ann Neurol, 3, 129, 10.1002/ana.410030207 Lin, 2012, Promoter methylation analysis of seven clock genes in Parkinson's disease, Neurosci Lett, 507, 147, 10.1016/j.neulet.2011.12.007 Lorefalt, 2004, Factors of importance for weight loss in elderly patients with Parkinson's disease, Acta Neurol Scand, 110, 180, 10.1111/j.1600-0404.2004.00307.x Macia, 2004, Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight, Mov Disord, 19, 206, 10.1002/mds.10630 Matzuk, 1985, Preservation of hypothalamic dopaminergic neurons in Parkinson's disease, Ann Neurol, 18, 552, 10.1002/ana.410180507 McKeith, 2017, Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium, Neurology, 89, 88, 10.1212/WNL.0000000000004058 Meister, 2007, Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight, Physiol Behav, 92, 263, 10.1016/j.physbeh.2007.05.021 Montaurier, 2007, Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation, Brain, 130, 1808, 10.1093/brain/awm113 Nakamura, 1996, Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy, Neurology, 46, 1693, 10.1212/WNL.46.6.1693 Niwa, 2011, Circadian rhythm of rest activity and autonomic nervous system activity at different stages in Parkinson's disease, Auton Neurosci, 165, 195, 10.1016/j.autneu.2011.07.010 Overeem, 2002, Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness, Neurology, 58, 498, 10.1212/WNL.58.3.498 Pavese, 2011, Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study, Neuroimage, 56, 1463, 10.1016/j.neuroimage.2011.03.012 Peeraully, 2012, Sleep and Parkinson's disease: a review of case-control polysomnography studies, Mov Disord, 27, 1729, 10.1002/mds.25197 Plaschke, 1998, Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson's disease and multiple system atrophy, J Hypertens, 16, 1433, 10.1097/00004872-199816100-00006 Poewe, 2017, Parkinson disease, Nat Rev Dis Primers, 3, 17013, 10.1038/nrdp.2017.13 Politis, 2008, Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study, Exp Neurol, 214, 112, 10.1016/j.expneurol.2008.07.021 Purba, 1994, Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease, Neurology, 44, 84, 10.1212/WNL.44.1.84 Rao, 2008, Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus, J Neurosci, 28, 9101, 10.1523/JNEUROSCI.1766-08.2008 Ripley, 2001, CSF hypocretin/orexin levels in narcolepsy and other neurological conditions, Neurology, 57, 2253, 10.1212/WNL.57.12.2253 Ruzicka, 2012, Weight gain is associated with medial contact site of subthalamic stimulation in Parkinson's disease, PLoS One, 7, 10.1371/journal.pone.0038020 Saper, 2002, The central autonomic nervous system: conscious visceral perception and autonomic pattern generation, Annu Rev Neurosci, 25, 433, 10.1146/annurev.neuro.25.032502.111311 Saper, 2013, The central circadian timing system, Curr Opin Neurobiol, 23, 747, 10.1016/j.conb.2013.04.004 Saper, 2002, The need to feed: homeostatic and hedonic control of eating, Neuron, 36, 199, 10.1016/S0896-6273(02)00969-8 Sauleau, 2009, Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease, Mov Disord, 24, 2149, 10.1002/mds.22765 Shan, 2012, Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus, Neurobiol Aging, 33, 1343, 10.1016/j.neurobiolaging.2011.01.004 Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 Strowd, 2010, Weight change following deep brain stimulation for movement disorders, J Neurol, 257, 1293, 10.1007/s00415-010-5509-4 Struck, 1990, Circadian fluctuations of contrast sensitivity in Parkinson's disease, Neurology, 40, 467, 10.1212/WNL.40.3_Part_1.467 Stuber, 2016, Lateral hypothalamic circuits for feeding and reward, Nat Neurosci, 19, 198, 10.1038/nn.4220 Tan, 2018, Regulation of body temperature by the nervous system, Neuron, 98, 31, 10.1016/j.neuron.2018.02.022 Thannickal, 2007, Hypocretin (orexin) cell loss in Parkinson's disease, Brain, 130, 1586, 10.1093/brain/awm097 Toth, 1997, Free-living daily energy expenditure in patients with Parkinson's disease, Neurology, 48, 88, 10.1212/WNL.48.1.88 van der Marck, 2012, Body mass index in Parkinson's disease: a meta-analysis, Parkinsonism Relat Disord, 18, 263, 10.1016/j.parkreldis.2011.10.016 van Hilten, 1991, A new approach in the assessment of motor activity in Parkinson's disease, J Neurol Neurosurg Psychiatry, 54, 976, 10.1136/jnnp.54.11.976 van Hilten, 1993, Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring, Acta Neurol Scand, 87, 171, 10.1111/j.1600-0404.1993.tb04096.x Videnovic, 2014, ‘The clocks that time us'—circadian rhythms in neurodegenerative disorders, Nat Rev Neurol, 10, 683, 10.1038/nrneurol.2014.206 Videnovic, 2014, Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease, JAMA Neurol, 71, 463, 10.1001/jamaneurol.2013.6239 Walker, 2009, Weight changes associated with unilateral STN DBS and advanced PD, Parkinsonism Relat Disord, 15, 709, 10.1016/j.parkreldis.2009.01.009 Weber, 2016, Circuit-based interrogation of sleep control, Nature, 538, 51, 10.1038/nature19773 Wills, 2016, Association between change in body mass index, unified Parkinson's disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of longitudinal data from NINDS exploratory trials in Parkinson disease long-term study 1, JAMA Neurol, 73, 321, 10.1001/jamaneurol.2015.4265 Winner, 2011, In vivo demonstration that alpha-synuclein oligomers are toxic, Proc Natl Acad Sci U S A, 108, 4194, 10.1073/pnas.1100976108 Yamashita, 2017, Lateral hypothalamic circuits for sleep-wake control, Curr Opin Neurobiol, 44, 94, 10.1016/j.conb.2017.03.020 Zhong, 2013, The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson's disease, PLoS One, 8, 10.1371/journal.pone.0072661